Clinical trials
Completed Astigmatism trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
205 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 11 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 16 |
| 2014 | 12 |
| 2015 | 12 |
| 2016 | 13 |
| 2017 | 2 |
| 2018 | 22 |
| 2019 | 10 |
| 2020 | 12 |
| 2021 | 20 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 10 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 205 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 40 |
| CooperVision, Inc. | 33 |
| Johnson & Johnson Vision Care, Inc. | 15 |
| Bausch & Lomb Incorporated | 13 |
| Beaver-Visitec International, Inc. | 6 |
| CIBA VISION | 6 |
| Johnson & Johnson Surgical Vision, Inc. | 6 |
| Staar Surgical Company | 4 |
| Abbott Medical Optics | 3 |
| CooperVision International Limited (CVIL) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astigmatism | 205 |
| Myopia | 75 |
| Cataract | 42 |
| Refractive Errors | 27 |
| Hyperopia | 22 |
| Presbyopia | 18 |
| Aphakia | 8 |
| Lacerations | 2 |
| Surgical Wound | 2 |
| Amblyopia | 1 |
Trials
Showing 1 to 25 of 205. Each trial links to its page on Pharma Observatory.
105 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.